Reassessing Diginex (DGNX) Valuation After Sharp 90 Day Share Price Decline

Advertisement

Why Diginex (DGNX) is on investors’ radar

Diginex (DGNX) has attracted fresh attention after recent trading left the share price at $3.79, prompting investors to reassess how its ESG reporting and advisory business lines compare with its current financial profile.

See our latest analysis for Diginex.

That recent 1 day share price return of 6.42% and 30 day share price return of 52.21% feed into a much steeper 90 day share price decline of 87.93%, suggesting momentum has been fading as investors reassess Diginex’s risk and growth potential.

If Diginex has you rethinking where you want exposure in software and data driven themes, it could be a good moment to scan high growth tech and AI stocks as a fresh hunting ground for ideas.

With Diginex posting a 90 day share price decline of 87.93% while still generating US$3.57m of revenue alongside a US$9.86m loss, are you looking at a beaten down opportunity or a stock where markets already price in future growth?

Price-to-Book of 70.7x: Is it justified?

Diginex closed at $3.79, yet its P/B ratio of 70.7x signals that the market is paying a very high premium to the company’s book value compared with peers.

P/B compares the share price to net assets on the balance sheet, so a 70.7x reading means investors are valuing each dollar of equity at many times its accounting value. For a young, loss making software and ESG data company, that usually reflects high expectations for future value creation rather than current profitability.

Here, that premium sits alongside US$3.57m of revenue, a US$9.86m loss, a negative return on equity of 90.58% and less than one year of cash runway. Against that backdrop, the current P/B level suggests the market is paying far more for Diginex’s balance sheet than for the average software name.

The contrast is sharp when you line Diginex up against both its immediate peers on 5x P/B and the wider US software group on 3.5x P/B. This indicates a multiple that is many times higher than typical sector pricing.

See what the numbers say about this price — find out in our valuation breakdown.

Result: Price-to-book of 70.7x (OVERVALUED)

However, those expectations sit against a 90 day share price decline of 87.93% and a US$9.86m loss, so any setback in ESG demand or funding could rapidly reset sentiment.

Find out about the key risks to this Diginex narrative.

Build Your Own Diginex Narrative

If you see the numbers differently or want to stress test your own view, you can build a custom thesis in just a few minutes, starting with Do it your way.

A great starting point for your Diginex research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Do not stop with one stock; widen your watchlist using focused screeners that surface different types of opportunities before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqCM:DGNX

Diginex

An investment holding company, engages in the provision of environmental, social, and governance (ESG) reporting solution services, advisory, and developing customization solutions in Hong Kong, the United Kingdom, and the United States.

Moderate risk with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
47 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
67 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
185 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
71 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0